 |
A model of so called "BioNtainers",
a container-based production line of mRNA-based vaccines of German company
BioNTech, is pictured at the company's plant in Marburg, Germany, February 11,
2022. REUTERS/Fabian Bimmer/File Photo.
|
|
The
BioNtrainer is anticipated to arrive in Kigali, Rwanda in the first quarter of
2023, according to the manufacturer of the COVID-19 vaccine.
In
order to lessen what the World Health Organization has described as enormous
inequities in global availability to the COVID-19 vaccine, the company planned
to build a vaccine factory utilizing shipping containers and export it as
assembly kits to Africa.
The
first BioNtrainer will be housed at the Kigali facility, according to BioNtech,
and is anticipated to become a component of a larger supply chain that would
connect other African countries to the mRNA-based vaccine.
Source: Reuters
0 Comments